KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Guardant Health (GH) Accumulated Depreciation & Amortization (2017 - 2026)

Guardant Health's Accumulated Depreciation & Amortization history spans 9 years, with the latest figure at $39.7 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 6.25% to $39.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.7 million, a 6.25% decrease, with the full-year FY2025 number at $39.7 million, down 6.25% from a year prior.
  • Accumulated Depreciation & Amortization hit $39.7 million in Q4 2025 for Guardant Health, up from $29.7 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for GH hit a ceiling of $42.9 million in Q4 2023 and a floor of $5.0 million in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $22.6 million across 5 years, with a median of $21.2 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 61.47% in 2022 and later fell 7.04% in 2025.
  • Tracing GH's Accumulated Depreciation & Amortization over 5 years: stood at $22.3 million in 2021, then surged by 61.47% to $36.0 million in 2022, then increased by 19.24% to $42.9 million in 2023, then fell by 1.15% to $42.4 million in 2024, then fell by 6.25% to $39.7 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for GH at $39.7 million in Q4 2025, $29.7 million in Q3 2025, and $20.3 million in Q2 2025.